Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

IMW 2019 | Double oncogenic hits of 17p13(del) and 1q21(amp) in myeloma

Phaik Ju Teoh • 15 Sep 2019
IMW 2019
Multiple Myeloma

Dr. Phaik Ju Teoh, PhD, of the Cancer Science Institute of Singapore, Singapore explains her research on the prognosis of multiple myeloma patients harboring double oncogenic hits of 17p13(del) and 1q21(amp). This interview was recorded at the International Myeloma Workshop (IMW) 2019, in Boston, MA.

More from Phaik Ju Teoh

3:14
The influence of IL6R-ADAR1-STAT3 interplay on MM prognosis
Phaik Ju Teoh • 15 Sep 2019

Related Videos

0:59
Looking forward to COMy 2024: celebrating 10 years
Mohamad Mohty • 17 Apr 2024
0:57
Overcoming barriers to treating older patients with myeloma
Sergio Giralt • 16 Apr 2024
1:01
The potentially curative role of CAR-T therapy in myeloma
Sergio Giralt • 16 Apr 2024
1:45
Expanded approval of cilta-cel in myeloma: the value of bringing CAR-T cells into earlier lines
Monika Engelhardt • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals